VIVE News and Press, Viveve Medical Inc. From 03/17/22

Reported total revenue for year end 2021 of $6.4 million representing 17% year-over-year growth Enrollment completed in U.S. pivotal PURSUIT trial for stress urinary incontinence and 12-month post treatment follow-up visits underway PURSUIT top-line results anticipated at end of 20...

Viveve Medical (NASDAQ:VIVE) is scheduled to announce FY earnings results on Thursday, March 17th, after market close. The consensus EPS Estimate is -$2.52 and the consensus Revenue Estimate is $6.42M (+17.2% Y/Y). For further details see: Viveve Medical FY 2021 Earnings Preview

ASTR, AVPT, BIOL, BOXL, CBAY, DLNG, FDX, GME, HITI, INTZ, INUV, IPWR, ONTX, OTCPK:PWCDF, SPPI, STNE, USIO, VIVE For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Thursday's close

ENGLEWOOD, CO / ACCESSWIRE / March 3, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE) , a medical technology company focused on women's intimate health, today announced that it will report its full year 2021 financial results and provide a corporate update after the close of the U.S. financial ma...

Arenberg Capital initiates coverage of InMode stock with hold rating prior to the company's FY21 earnings on February 10, 2022. We ran multiple approaches to determine the fair valuation of this high-growth medtech company. Our DCF indicates a fair valuation at the current price l...

Viveve SVP Suzon Lommel named to list for second consecutive year for efforts to advance innovative technologies to treat stress urinary incontinence in women ENGLEWOOD, CO / ACCESSWIRE / January 13, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women'...

ENGLEWOOD, CO / ACCESSWIRE / January 4, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health, today announced that Scott Durbin, chief executive officer, will participate in the H.C. Wainwright BIOCONNECT Conference, January 10 - 13, 2022. Mr. D...

Major milestone achieved in Company's advance toward a new U.S. SUI indication ENGLEWOOD, CO / ACCESSWIRE / December 14, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, announced today that it has completed enrollment in its pi...

Viveve Medical, Inc. (VIVE) Q3 2021 Earnings Conference Call November 11, 2021, 05:00 PM ET Company Participants Jeannie Swindle - Senior Director of Corporate Communications Jim Robbins - SVP of Finance and Administration Scott Durbin - CEO Conference Call Participants Presentation Operator ...

Viveve Medical (NASDAQ:VIVE): Q3 GAAP EPS of -$0.67 misses by $0.10. Revenue of $1.6M (+5.3% Y/Y) misses by $0.09M. Press Release For further details see: Viveve Medical EPS misses by $0.10, misses on revenue